STUDIES ON THE CARBOXYMETHYL CHITOSAN-CONTAINING LIPOSOMES FOR THEIR STABILITY AND CONTROLLED RELEASE OF DAPSONE

被引：29

作者：

ALAMELU, S

RAO, KP

机构：

[1] Biomaterials Laboratory, Central Leather Research Institute, Adyar, Madras

来源：

JOURNAL OF MICROENCAPSULATION | 1991年 / 8卷 / 04期

关键词：

D O I：

10.3109/02652049109021874

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

Stable liposomes containing carboxymethyl chitosan (CMC) were prepared and characterized. CMC was introduced in the phosphatidyl choline (PC) liposomes by different methods; firstly, CMC in a free state in the aqueous phase; secondly as a coat (coupled); and finally as a conjugate of dapsone. The stability of liposomes was assessed by their disintegration in ethanol and surfactants. Both hydrophilic bromothymol blue and lipophilic dapsone were encapsulated in these liposomes and their in vitro release studies were carried out at 37-degrees-C using different media, namely, phosphate buffer (pH 7.4), 0.02 N-HCl and 1% mouse plasma. The conjugate of dapsone with CMC present in PC liposomes gave the best results in its stability as compared to other modified liposomes. The release data of dapsone also confirmed the results of the stability studies on liposomes. CMC-dapsone conjugate released the dapsone much slower in all three media than did PCCMC and PCCMC-coat liposomes.

引用

页码：505 / 519

页数：15

共 15 条

[1]

Alamelu S., Panduranga Rao K., Effect of surfactants on the stability of modified egg-yolk phosphatidylcholine liposomes, Journal of Microencapsulation, 7, 4, pp. 541-551, (1990)

[2]

Bratton A.C., Marshall E.K., A new coupling component for sulfanilamide determination, Journal of Biological Chemistry, 128, pp. 537-550, (1939)

[3]

Ellard G.A., Bammon P.T., Helmy H.S., Rees R.J.W., Urine tests to monitor the self-administration of dapsone by leprosy patients, American Journal of Tropical Medicine and Hygiene, 23, 3, pp. 464-470, (1974)

[4]

Grunwald R., Painter G.R., The effects of lipid composition on the binding of lasolocid A to small unilamellar vesicles, Biochimica et Biophysica Acta, 1027, 3, pp. 245-252, (1990)

[5]

Hughes B.J., Kennel S., Lee R., Huang L., Monoclonal antibody targeting of liposomes to mouse lung in vivo, Cancer Research, 49, pp. 6214-6220, (1989)

[6]

Kirby C., Clarke J., Gregoriadis G., Effect of cholesterol content of small unilamellar liposomes on their stability in vivo and, Biochemical Journal, 186, pp. 591-598, (1980)

[7]

Klibanov A.L., Maruyama K., Torchilin V.P., Huang L., Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes, FEBS Letters, 268, 1, pp. 235-237, (1990)

[8]

Mayer L.D., Tai L.C.L., Ko D.S.C., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B., Influence of vesicle size, lipid composition and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice, Cancer Research, 49, pp. 5922-5930, (1989)

[9]

Senior J.H., Fate and behaviour of liposomes in vivo

[10]

a review of controlling factors. CRC Critical Reviews in, Therapeutic Drug Carrier Systems, 3, pp. 123-193, (1987)

← 1 2 →